Impact of Previous Stroke on Clinical Outcome in Elderly Patients With Nonvalvular Atrial Fibrillation: ANAFIE Registry | Stroke
Balancing Benefits and Risks of Long-Term Antiplatelet Therapy in Noncardioembolic Transient Ischemic Attack or Stroke | Stroke
A review of neurological side effects of COVID-19 vaccination | European Journal of Medical Research | Full Text
IJERPH | Free Full-Text | Stroke and TIA Survivors’ Perceptions of the COVID-19 Vaccine and Influences on Its Uptake: Cross Sectional Survey
COVID-19 infection has greater risk than vaccines of causing very rare neurological events — Nuffield Department of Clinical Neurosciences
Cardiovascular and haematological events post COVID‐19 vaccination: A systematic review - Al‐Ali - 2022 - Journal of Cellular and Molecular Medicine - Wiley Online Library
Underlying causes of cryptogenic stroke and TIA in The Nordic Atrial Fibrillation and Stroke (NOR-FIB) Study – the importance of comprehensive clinical evaluation | BMC Neurology | Full Text
Industry Symposium: Clinical Considerations in Stroke or TIA
Disease Burden Following Non-Cardioembolic Minor Ischemic Stroke or High-Risk TIA: A GWTG-Stroke Study - ScienceDirect
Tia Bennett - Senior Respiratory Biologics Sales Specialist - AstraZeneca | LinkedIn
Entwicklungenin der Sekundärprävention des ischämischen Schlaganfalles und der TIA
Randomized Trial of Aspirin Versus Warfarin After Transcatheter Aortic Valve Replacement in Low-Risk Patients | Circulation: Cardiovascular Interventions
Consent form for COVID-19 vaccination - 21102021 - Gilbertese
Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack | Stroke
When to get your COVID-19 vaccination - Gilbertese
Time Course for Benefit and Risk of Ticagrelor and Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack | Neurology
THALES Efficacy | BRILINTA® (ticagrelor) tablets | For HCPs
Dual Antiplatelet Therapy Versus Aspirin in Patients With Stroke or Transient Ischemic Attack: Meta-Analysis of Randomized Controlled Trials | Stroke
Five-Year Risk of Stroke after TIA or Minor Ischemic Stroke | NEJM
Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA | NEJM
Diagnosis, Workup, Risk Reduction of Transient Ischemic Attack in the Emergency Department Setting: A Scientific Statement From the American Heart Association | Stroke
g57001ku13i005.gif
JCM | Free Full-Text | Challenges of Acute Ischemic Stroke Treatment in Orally Anticoagulated Patients via Telemedicine
THALES Secondary Efficacy | BRILINTA® (ticagrelor) tablets | For HCPs
